Impact of dupilumab and upadacitinib treatment on epigenetic and transcriptomic alterations in skin-homing T cells of atopic dermatitis patients
Ahmed M I Elfiky, Hidde M. Smits, Marlot van der Wal, Coco Dekkers, Celeste Mirte Boesjes, Julia Drylewicz, Marjolein S. de Bruin-Weller, Femke van Wijk
This study examines how dupilumab and upadacitinib affect epigenetic and transcriptomic changes in skin-homing T cells of atopic dermatitis patients over one year of treatment.
Clinical & Experimental Allergy · Jul 15, 2026Peer-reviewedImmunology